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Human papillomavirus (HPV) infections are strongly associated with the development of cervical intraepithelial 
neoplasias and invasive cervical cancer. Polymorphisms in cytokine-encoding genes and behavioural cofactors 
could play an important role in protecting an individual against viral infections and cancer. Here, we investigated 
whether IL-6 -174 G>C, IL-8 +396 G>T, and TGF-β1 +869 G>C and +915 G>C polymorphisms were associated 
with susceptibility to HPV infection in women from north-east (Pernambuco) Brazil. We analysed 108 healthy unin-
fected women (HC) and 108 HPV-positive women with cervical lesions. Genetic polymorphisms were assessed using 
Sanger sequencing and polymerase chain reaction-restriction fragment length polymorphism. Comparison of the 
distribution of the genotypic and allelic frequencies of the IL-18 +396 T>G polymorphism between HPV infected 
woman an uninfected controls showed that the GG genotype and G allele were both more frequent in the HC group, 
and were associated with protection from HPV infection (p = 0.0015; OR = 0.29 CI95% = 0.13-0.61; p = 0.0005; OR 
= 0.45 CI95% 0.29-0.7, respectively). Individuals from the control group could have previously had HPV infection 
that was spontaneously eliminated; however, it was undetectable at the time of sample collection. Based on our find-
ings, we hypothesize that the IL-8 +396 G>T polymorphism could interfere with susceptibility to HPV infection, by 
modulating the ability of immune system to fight the virus.
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Cervical cancer represents a significant public health 
problem causing a great impact worldwide; every year 
approximately 528,000 new cases and 266,000 deaths 
(7.5% of all female cancers) are expected (IARC 2012). 
In Brazil, cervical cancer is the second most common 
type of cancer among women. Approximately 16,340 
new cases are expected for 2016, representing 15.85 cas-
es per 100,000 individuals (INCA 2016). Infections with 
oncogenic types of the human papillomavirus (HPV) are 
responsible for most cases of cervical cancer and precan-
cerous intraepithelial lesions (Muñoz et al. 2003).
Although the incidence of genital HPV infections is 
high, most of these infections are transient and do not 
lead to cervical intraepithelial neoplasia (CIN) or cancer, 
suggesting that other factors such as the immune system 
as well as the host genetic background could influence 
disease risk (Wu & Levine 1994).
HPV infection promotes immune cell migration to 
the dermis. In the squamous epidermis, macrophages, 
Langerhans cells (LC), T lymphocytes, dendritic cells 
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(DC), natural killer cells (NK), and B-lymphocytes play 
important roles in the immune response to infection. 
HPV infection could induce the immune system to be-
come more tolerant to the infection, thereby creating a 
microenvironment susceptible to further infection, facil-
itating CIN progression (Song et al. 2015).
These local immune responses seem to play an im-
portant role in the natural history of HPV infection of the 
uterine cervix. Cytokines are important regulators of HPV 
transcription due to their important role in the defence 
against HPV infection, through modulating viral replica-
tion (zur Hausen 2002). Polymorphisms in genes related to 
immunity have been reported to influence susceptibility 
to several diseases including viral infections. Therefore, 
these polymorphisms should also be considered when 
analysing the genetic susceptibility to HPV infection as 
well as cervical cancer (Wang & Hildesheim 2003).
The discovery of a TH17 variant has improved the 
understanding of inflammatory processes. TH17 cells 
are linked to chronic neutrophilic inflammation and 
can be induced to differentiate by transforming growth 
factor β1 (TGF-β1) and interleukin-6 (IL-6). Therefore, 
TGF-β1 and IL-6 can also induce the differentiation of 
TH9 and TH22 cells, respectively (both linked to tissue 
inflammation) (Akdis et al. 2011).
The IL-6 gene, located on the short arm of human 
chromosome 7 (7p21), presents several single nucleotide 
polymorphisms (SNPs), one of which is localised in the 
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promoter region (-174G>C, rs1800795), and is associated 
with variations in IL-6 expression and on serum protein 
levels (Fishman et al. 1998). This SNP correlates with 
poor prognosis in gastric cancer (de Vita et al. 2001) and 
prostate cancer (Nakashima et al. 2000). Moreover, IL-6 
seems to be involved in cervical cancer progression and 
metastasis (Kinoshita et al. 1999, de Vita et al. 2001).
TGF-β1, a fundamental molecule involved in the 
homeostasis between cellular growth and apoptosis, 
is encoded by the TGF-β1 gene located on the long 
arm of human chromosome 19 (19q13). The +869 T>C 
(rs1982073) SNP is located at codon 10 of exon 1 and 
results in a leucine-to-proline substitution, whereas 
+915 G>C (rs1800471) is located at codon 25 and results 
in an arginine-to-proline change. The C variant allele 
of codon 10, as well as the wild-type G allele of codon 
25, is associated with increased production of TGF-β1 
(Dunning et al. 2003). Furthermore, circulating levels 
of TGF-β1 have been associated with several diseases, 
including cancer (Elliott & Blobe 2005).
Interleukin-8 (IL-8), the first chemokine discovered, 
has pro-inflammatory activity, and is produced as part 
of immune or acute inflammatory reactions, as well as 
during chronic inflammation; this cytokine functions to 
attract and activate neutrophils in inflammatory regions 
(Campa et al. 2005). The IL-8 gene is located on the long 
arm of chromosome 4 (4q12-q21) and several promoter, 
intron, and 3′UTR SNPs have been identified (Hull et al. 
2001). The IL-8 +396 G>T (rs2227307) polymorphism 
has been associated with respiratory diseases caused by 
viruses (Hull et al. 2001) and gastric cardiac adenocarci-
noma (Savage et al. 2004).
Since few studies have been performed correlating 
SNPs in IL-6, IL-8, and TGF-β1 genes with the risk of 
HPV infection, we evaluated whether IL-6 (-174 G>C), 
IL-8 (+396 G>T), and TGF-β1 (+869 T>C and +915 G/C) 
functional genetic variants were related to HPV suscep-
tibility, by studying HPV infected and uninfected wom-
en from Pernambuco, Brazil.
SUBJECTS, MATERIALS AND METHODS
Patients - A hospital-based cross-sectional study was 
performed aimed at analysing IL-6, IL-8, and TGFβ1 
gene polymorphisms in HPV-infected women with cer-
vical lesions and invasive cervical cancer (ICC). One 
hundred and eight women aged 17-68 years, with a mean 
age of 33.9 ± 10.1 years, presenting with either low-grade 
squamous intraepithelial lesion (LSIL) or high-grade 
squamous intraepithelial lesion (HSIL), were selected 
from the outpatient clinics of the Lower Genital Tract 
Pathology Clinic at the Women’s Healthcare Centre of 
the Prof Fernando Figueira Institute of Integrated Medi-
cine, (Recife, Pernambuco, Northeast Brazil). Patients 
were selected by spontaneous demand from January 
2009 to December 2010. Patients were included in the 
study if there was no discrepancy between cytological 
abnormality and histological diagnosis made at the first 
visit. All patients were initially assessed by colposcopy 
and subsequently cervical smears were collected. Histo-
logical diagnosis was made according to the Associação 
Brasileira de Genitoscopia (ABG 2002). Subjects were 
evaluated for clinical features of other sexually transmit-
ted infections (STIs) based on history and examination. 
Patients who were previously submitted to radiotherapy 
or chemotherapy for ICC were excluded. Patients were 
also stratified according to age, parity, number of part-
ners, smoking, and alcohol consumption.
One hundred and eight unrelated women from Per-
nambuco, enrolled at the Women’s Healthcare Centre, the 
same as that of HPV infected patients, aged between 14-66 
years (mean age 37.2 ± 10 years), with no history of lesions 
or neoplastic disease as evaluated by the physician, and 
testing negative for HPV infection, were used as controls.
Informed written consent was obtained from the 
women, and the women were informed of the back-
ground of the study, risks and benefits, and voluntary 
nature of participation (CEP/CCS/UFPE Nº 355/08).
Clinical samples - Cervical smears were obtained 
using cytobrushes. Each cytobrush was packed in a TE 
buffer solution (10 mM Tris-HCl and 1 mM EDTA, pH 
8.0) and maintained at -20ºC until analysis.
DNA extraction - Genomic DNA extraction was per-
formed from 300 µL of cervical smear, from each study 
subject, using the Wizard Genomic DNA Purification kit 
(Promega, Madison, WI, USA) following the manufac-
turer’s instructions. The analyses were executed in Lab-
oratory of Genetic, Biochemistry and DNA Sequencing 
(LGBS) of Rural Federal University of Pernambuco.
HPV DNA detection - Human papillomavirus DNA 
was detected from DNA extracted as previously de-
scribed using two polymerase chain reaction (PCR) 
steps. The first was with MY09/11 external primers 
(MY09 5′-CGTCCMARRGGAWACTGATC-3′ and 
MY11 5′-GCMCAGGGWCATAAYAATGG-3′) and the 
second was with GP05+/06+ (GP5+ 5′-TTTGTTACT-
GTGGTAGATACTAC-3′ and GP6+ 5′-GAAAAATA-
AACTGTAAATCATATTC-3′) as internal ones. These 
two primers pairs are most widely used for the detec-
tion of genital HPVs. A negative control containing only 
digestion buffer was included for every five samples to 
prevent and detect carry-over between samples.
IL-6, IL-8, and TGF-β1 SNPs genotyping - IL-6 and 
TGF-β1 polymorphisms were amplified from the same 
DNA utilised for HPV detection, using specific prim-
ers (IL-6 - 5′-TTGTCAAGACATGCCAAAGTG-3′ and 
5′-TCAGACATCTCCAGTCCTATA-3′ and TGF-β1 
- 5′-TTCCCTCGAGGCCCTCCTA-3′ and 5′-GCCG-
CAGCTTGGACAGGATC-3′) which flanked the poly-
morphisms. PCR was performed following standard 
protocols from the literature. Briefly, after amplifica-
tion, the amplicons were submitted to a sequencing re-
action using the DyEnamic ET Dye Terminator Cycle 
sequencing kit (GE Healthcare) according to manufac-
turer’s recommendations and were sequenced using a 
MegaBACE 1000 DNA Sequencer.
IL-8 was amplified from the same DNA utilised 
for HPV detection using specific primers (5 ′-TA-
AAGGTTTGATCAATATAGA-3′ and 5′-CTTCCTTC-
TAATTCCAATATG-3′) according to literature, and the 
genotypes were identified through restriction fragment 
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analysis polymerase chain reaction-restriction fragment 
length polymorphism (PCR-RFLP) using the ScrFI re-
striction enzyme. Thirty per cent of the samples were 
sequenced to confirm the results.
Statistical analysis - Univariate statistical analy-
sis was performed using BioEstat 5.0 software. The 
study was cross-sectional, with independent samples 
consisting of nominal data (genotypes). The influence 
of polymorphism on the risk for development of (pre) 
neoplastic cervical disease was estimated by an odds 
ratio (OR) and a 95% confidence interval (CI). Allele 
frequencies were estimated by direct counting. Com-
parison between genotypic frequencies of patients and 
control groups was performed using a χ2 test; a Fisher’s 
exact test was used to compare the allele frequencies in 
contingency tables. The OR and their respective 95% 
CI values were determined. All p values ≤ 0.05 were 
considered statistically significant.
RESULTS
Selected characteristics, including age, age of first 
sexual coitus, parity, smoking status, alcohol consump-
tion, and oral contraceptive use of 108 HPV infected 
women with cervical lesions are summarised in Table 
I; 44 women (40.74%) were over 35 years of age; 73 
(67.6%) were younger than 18 at the time of first sexu-
al intercourse; 23 (21.3%) had a parity of five or more; 
64 (59.3%) women reported regular use of alcohol; 41 
(37.9%) women were smokers, and 55 (50.9%) women 
reported the use of oral contraceptives. There was no 
significant difference between women with HSIL and 
LSIL in terms of age of first sexual intercourse (p = 
0.3787), parity (p = 0.5637), smoking (p = 0.8130), al-
cohol consumption (p = 0.9781), and oral contraception 
use (p = 0.9247). HSIL and LSIL were more frequent in 
subjects aged ≥ 35 years than in subjects < 35 years of 
age (p = 0.0124) (Table I).
Table II shows the distribution of genotypes and allele 
frequencies of IL-6 (-174 G>C), IL-8 (+396 T>G), and 
TGF-β1 (+869 G>C) and (+915 G>C) polymorphisms in 
HPV infected women and healthy uninfected controls. 
IL6 and TGF-β1 (+869 T>C) and (+915 G>C) polymor-
phism frequencies were in Hardy-Weinberg equilibrium 
in HPV infected women and uninfected controls, where-
as the IL-8 +396 T>G polymorphism showed frequen-
cies not in agreement with the Hardy-Weinberg equilib-
rium in the two groups of subjects analysed.
IL-6 -174 G>C and TGF-β1 +869 T>C and +915 G>C 
polymorphism alleles and genotype frequencies were 
not statistically different between HPV infected wom-
en and healthy uninfected controls. Comparison of the 
IL-8 +396 T>G polymorphism allele and genotype fre-
quencies between HPV infected woman and uninfected 
controls showed a statistically significant increase in the 
frequency of the GG genotype in uninfected subjects 
compared to HPV infected women, suggesting an asso-
ciation between this allele and protection from HPV in-
fection (p = 0.0015; OR = 0.29 CI95% 0.13-0.61). In ad-
dition, the prevalence of the G allele was more frequent 
in HCs than in HPV infected women, thus, suggesting 
an association between this allele and protection from 
HPV infection (p =0.0005; OR = 0.45 CI95% 0.29-0.70).
TABLE I
Associations of clinical characteristics between human papillomavirus infected women with high-grade squamous  
intraepithelial lesions (HSIL) and those with low-grade squamous intraepithelial lesions (LSIL)
LSIL HSIL OR 95%CI P
Age
< 35 18 (85.7%) 46 (52.9%) 1
≥ 35 3 (15.3%) 41 (47.1%) 5.35 1.47 - 19.48 0.0124*
AFSI
 > 18 years old 9 (42.8%) 26 (29.9%) 1
 < 18 years old 12 (57.2%) 61 (70.1%) 1.76 0.66 - 4.68 0.3787
Parity
< 5 births 18 (85.7%) 67 (77%) 1
≥ 5 births 3 (15.3%) 20 (23%) 1.79 0.48 - 6.70 0.5637
Smoking
No 14 (66.7%) 53 (60.9%) 1
Yes 7 (33.3%) 34 (39.1%) 1.28 0.47 - 3.50 0.8130
Alcohol consumption
No 8 (38.1%) 36 (41.4%) 1
Yes 13 (61.9%) 51 (58.6%) 0.87 0.33 - 2.32 0.9781
OCP use
No 11 (52.4%) 42 (48.3%) 1
Yes 10 (47.6%) 45 (51.7%) 1.18 0.45 - 3.06 0.9247
AFSI: age of first sexual intercourse; OCP use: oral contraceptive use; OR: odds ratio; 95%CI: 95% confidence interval; P: p-value; 
*: statistically significant.
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In addition, with the aim of comparing the allele fre-
quencies of the SNPs observed in our study with those of 
the population from Pernambuco, we inferred the allele 
frequencies (indicated as f in the equation below; p in-
dicates proportion) for each polymorphism based on the 
equation presented by Suárez-Kurtz et al. (2014):
f_Brazil = (fPortugal * pEuropean) + (f(Angola+Mozambique) * p_African) 
+ (fGuarani * p_Amerindian)
Essentially, this equation calculates a weighted av-
erage of the allele frequency observed in the parental 
populations of Brazil, considering the proportion of each 
ancestry found in the Brazilian population. Since we had 
no data regarding the populations described in the equa-
tion, we used the findings of some related populations 
with available data present in the 1000 Genomes Project 
database (http://browser.1000genomes.org) as proxies.
For each polymorphism, we obtained the allele fre-
quencies from European Iberian (IBS), African Yoru-
ba (YRI), and Peruvian South American (PEL) genome 
databases and combined the frequencies considering 
the admixture of the Pernambuco population, compris-
ing genomes resulting from European (59.7%), African 
(23%), and Amerindian (17.3%) ancestries, as described 
in Coelho et al. (2015).
The predicted admixed frequencies for each polymor-
phism were as follows: 0.22 for the IL-6 (-174 G>C) poly-
morphism; 0.41 for the IL-8 (+396 T>G) polymorphism; 
0.46 for TGF-β1 (+869 T>C); 0.03 for the TGF-β1 (+915 
G>C) SNP. Finally, no significant differences in the dis-
TABLE II
Allele and genotype frequencies of IL-6 (-174 G>C), IL-8 (+396 G>T), and TGF-β1 (+869 G>C) and (+915 G>C)  
polymorphisms among human papillomavirus (HPV) positive women and healthy uninfected controls  
from Pernambuco state (Northeast Brazil)
HPV infected women Healthy uninfected controls OR (CI 95%) P value
IL6
Allele n = 216 (Freq) n = 216 (Freq)
G 172 (0,8) 163 (0,75) Ref
C 44 (0,2) 53 (0,25) 0,79 (0,5 - 1,24) 0,3563
Genotype n = 108 (Freq) n = 108 (Freq)
G/G 67 (0,62) 64 (0,59) Ref 0,2027
G/C 38 (0,35) 35 (0,32) 1,04 (0,58 - 1,84) 0,9829
C/C 3 (0,03) 9 (0,08) 0,32 (0,08 - 1,23) 0,152
IL8
Allele n = 216 (Freq) n = 216 (Freq)
T 174 (0,81) 141 (0,65) Ref
G 42 (0,19) 75 (0,35) 0,45 (0,29 - 0,7) 0,0005*
Genotype n = 108 (Freq) n = 108 (Freq)
T/T 77 (0,71) 66 (0,61) Ref 0,0003*
T/G 20 (0,19) 9 (0,08) 1,9 (0,81 - 4,47) 0,1964
G/G 11 (0,1) 33 (0,31) 0,29 (0,13 - 0,61) 0,0015*
TGF-β1+869T/C
Allele n = 216 (Freq) n = 216 (Freq)
T 131 (0,61) 131 (0,61) Ref
C 85 (0,39) 85 (0,39) 1 (0,68 - 1,47) 0,9215
Genotype n = 108 (Freq) n = 108 (Freq)
T/T 40 (0,37) 37 (0,34) Ref 0,6905
T/C 51 (0,47) 57 (0,53) 0,83 (0,46 - 1,49) 0,628
C/C 17 (0,16) 14 (0,13) 1,12 (0,49 - 2,59) 0,9528
TGF-β1+915G/C
Allele n = 216 (Freq) n = 216 (Freq)
G 210 (0,97) 207 (0,96) Ref
C 6 (0,03) 9 (0,04) 0,66 (0,23 - 1,88) 0,5992
Genotype n =n108 (Freq) n = 108 (Freq)
G/G 102 (0,94) 99 (0,92) Ref
G/C 6 (0,06) 9 (0,08) 0,65 (0,22 - 1,89) 0,5924
C/C 0 (0) 0 (0)
CI95%: 95% confidence interval; OR: Odds ratio; Ref: reference Allele; *: statistically significant.
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tribution of IL-6 (-174 G>C), IL-8 (+396 T>G), TGF-β1 
(+869 T>C), and (+915 G>C) polymorphisms were ob-
served between LSIL and HSIL groups (Table III) in HPV 
infected women.
DISCUSSION
Since HPV infection is a multifactorial process, de-
pending on environmental and host genomic factors, 
with particular focus on immunoregulatory genes, we 
analysed the possible impact of genetic variants, namely 
IL-6 (-174 G>C), IL-8 (+396 T>G), and TGF-β1 (+869 
T>C) and (+915 G>C) (cytokines encoding genes), on 
the susceptibility to HPV infection in women (HPV in-
fected and uninfected) from Pernambuco (Brazil).
We did not find any significant association between 
the IL-6 +174 G>C polymorphism and HPV infected 
women or uninfected controls, or between HSIL and LSIL 
subgroups; we also did not find any relationship between 
TGF-β1 +869 T>C and +915 G>C polymorphisms and the 
risk of HPV infection or the development of LSIL or HSIL. 
IL-6 and TGF-β1 polymorphisms were not associated with 
the development of cervical cancer in a population from 
Zimbabwe, Africa (Stanczuk et al. 2002), and in a popula-
tion from Shaaxi, China (Wang et al. 2011). In Brazil, Fer-
nandes et al. (2008) did not find any correlation between 
TGF-β1 +869 G>C and +915 G>C polymorphisms and the 
risk for HPV-related cervical lesions in women from São 
Paulo. Marangon et al. (2013) reported similar findings in 
HPV infected women from Paraná, Brazil.
Analysis of the IL-8 +396 T>G polymorphism re-
vealed an increased frequency of the TT genotype in 
HPV infected women, whereas the GG genotype and the 
G allele were both more frequent in healthy uninfected 
women, and were thus associated with protection from 
HPV infection.
It is worth noting that both HPV and HC groups were 
not in Hardy-Weinberg Equilibrium for the IL-8 +396 
T>G SNP due to an excess of homozygosity when com-
pared to the expected genotype frequencies predicted for 
the general population of Recife. Furthermore, the mi-
nor allele frequency of this polymorphism in both HPV 
(0.19) and HCs (0.35) was reduced in comparison to that 
predicted by ancestry estimates (0.41). Therefore, more 
studies are needed to investigate the lower than expected 
heterozygosity in this population.
IL-8, a chemokine, acts by attracting granulocytes 
to sites of inflammation, resulting in neutrophil-medi-
ated viral clearance (Knall et al. 1997). IL-8 expression 
is primarily regulated by an activator protein and/or nu-
clear factor-κB-mediated transcriptional activity, which 
is a critical regulator of the immediate early pathogen 
response that acts in response to bacterial and viral in-
fections (Brat et al. 2005).
IL-8 has been hypothesized to play an important role 
in ovarian cancer (Kassim et al. 2004). Increased IL-8 
serum levels were related to HPV persistence (Baker et 
al. 2011); IL-8 has been also reported to be involved in 
the epithelial-mesenchymal transition and the tumour mi-
croenvironment (Palena et al. 2012). Some viruses such as 
Herpes Simplex Virus (HSV), Epstein-Barr Virus (EBV), 
Human Immunodeficiency Virus (HIV) and Human T 
Lymphotropic Virus (HTLV-1) have been shown to in-
duce IL-8 expression through the Nuclear Factor-κB (NF-
κB) pathway (Mogensen & Paludan 2001).
TABLE III
Association of IL-6 (-174 G>C), IL-8 (+396 T>G), and TGF-β1 (+869 G>C) and (+915 G>C) polymorphisms  
among human papillomavirus (HPV) positive women with high-grade squamous intraepithelial lesions (HSIL)  
and those with low-grade squamous intraepithelial lesions (LSIL)
LSIL HSIL OR 95%CI P LSIL HSIL OR 95%CI P
IL-6 TGF-β1+869 T/C
GG 13 (61.9%) 54 (62.1%) 1 TT 11 (52.4%) 29 (33.3%) 1
GC 7 (33.3%) 31 (35.6%) 1.07 0.38 - 2.95 0.8923 TC 8 (38.1%) 43 (49.5%) 2.04 0.73 - 5.68 0.2343
CC 1 (4.8%) 2 (2.3%) 0.48 0.8827 CC 2 (9.5%) 15 (17.2%) 2.84 0.56 - 14.53 0.3420
G 33 (78.6%)
139 
(79.9%)
1 T 30 
(71.4%)
101 
(58.1%)
1
C 9 (21.4%) 35 (20.1%) 0.92 0.40 - 2.11 0.9811 C 12 (28.6%) 73 (41.9%) 1.81 0.87 - 3.76 0.1564
IL-8 TGF-β1+915 G/C
GG 1 (4.8%) 10 (11.5%) 1 GG 20 
(95.2%)
82 
(94.2%)
1
GT 8 (38.1%) 12 (13.8%) 0.15 0.02 - 1.41 0.1614 GC 1 (4.8%) 5 (5.8%) 1.22 0.13 - 11.03 0.7235
TT 12 (57.1%) 65 (74.7%) 0.54 0.06 - 4.63 0.9096 CC 0 (0%) 0 (0%) nd
G 10 
(23.8%)
32 (18.4%) 1 G 41 (97.6%) 169 
(97.1%)
1
T 32 (76.2%)
142 
(81.6%)
1.39 0.62 - 3.11 0.5625 C 1 (2.4%) 5 (2.9%) 1.21 0.14 - 10.67 0.7273
OR: odds ratio; 95%CI: 95% confidence interval; P: p-value.
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Differential expression of IL-8 could be associated 
with the presence of functional polymorphisms such 
as the IL-8 +396 G/T. The IL-8 +396 GG genotype is 
known to yield higher levels of IL-8 and has been linked 
to the development of ovarian carcinoma (Wang et al. 
2012). Therefore, we hypothesize that individual carri-
ers of the IL-8 +396 GG genotype, associated with high 
levels of IL-8, are better able to control HPV infection 
through the attraction of granulocytes to the sites of in-
fection. Consequently, this would results in successful 
neutrophil-mediated viral clearance. Nevertheless, this 
is a hypothesis that needs to be verified by analysing IL8 
serum levels, was not possible to analyse in this study. 
Moreover, the IL-8 +396 T/G polymorphism allele and 
genotype frequencies assessed in HPV infected and un-
infected women were not in Hardy-Weinberg equilibri-
um and were different from those inferred for the Per-
nambuco population. Therefore, our findings should be 
considered with caution and thus need to be replicated in 
at least one other north-east Brazilian population.
We are also aware that the main limitation of this 
study is the relatively small cohort enrolled; further-
more, HPV high-risk and low-risk genotyping data were 
not available to us; therefore, it was impossible to eval-
uate the impact of HPV genotypes on the susceptibility 
to cervical lesions as well as their relationship with cy-
tokine-encoding gene polymorphisms.
In conclusion, taking into account the fact that in-
dividuals from the control group could have been pre-
viously infected by HPV that was spontaneously elim-
inated, and based on our findings, we hypothesize that 
the IL-8 +396 G allele and GG genotypes could play a 
role in the risk of HPV infection in our study population. 
Specifically, carriers of these genetic variants, respon-
sible for higher IL-8 production, should be able to react 
better to HPV infection. This work will prompt future 
genetic studies regarding the molecular pathogenesis of 
HPV infection and similar analyses should be performed 
to determine whether this polymorphism could serve as 
a prognostic risk factor for HPV infection.
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